Home / Pharmaceutical company intelligence
Schazoo Zaka (Pvt) Ltd logo
Pharmaceutical company intelligence

Schazoo Zaka products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Sheikhupura · Pakistan

Long-established pharmaceutical manufacturer in Sheikhupura with a broad product range and particular strength in anti-tuberculosis medicines.

Schazoo Zaka products in Pakistan

Schazoo Zaka (Pvt) Ltd has 60 medicine presentations registered in Pakistan under 31 brands, covering 27 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are Rifapin (Rifampicin, Rifampicin + Isoniazid), Telmipin (Telmisartan + Amlodipine), Respimax (Clarithromycin) and Bizole (Ribavirin). 60 products have an official DRAP price on MedInfoBase. See all 31 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date22 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 23 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Schazoo Zaka (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Zaka-ur-Rehman Estate, Kalalwala, 20 KM Lahore-Jaranwala Road, District Sheikhupura, Pakistan
Official contact
Contact page ↗
Corporate source details checked
23 Aug 2026
Corporate profile completeness
75%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000636 Schazoo Zaka (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000636 60 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Website source ↗ Logo Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx65public portfolio records represented
REG61unique registrations represented
IDX60indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+3registry-only registrations
VER42registry-verified exact registrations
PKR60current validated price records
G27generic molecules in indexed catalogue
DF5dosage-form groups
TA7therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSchazoo Zaka (Pvt) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/schazoo-zaka-pvt-ltdGenerated 11 Nov 2026Anti-infectives41 · 68%Cardiovascular11 · 18%CNS & mental health3 · 5%Pain & musculoskeletal2 · 3%Hematology & thrombosis1 · 2%Vitamins, minerals & nutrition1 · 2%Gastrointestinal & hepatology1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSchazoo Zaka (Pvt) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/schazoo-zaka-pvt-ltdGenerated 11 Nov 202660presentationsTablet48 · 80%Capsule8 · 13%Suspension2 · 3%Drops1 · 2%Syrup1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSchazoo Zaka (Pvt) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/schazoo-zaka-pvt-ltdGenerated 11 Nov 202652comparable productsBelow peer median8 · 15%Near peer median9 · 17%Above peer median35 · 67%Company median price position+9.1%Lowest-price equivalents3Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSchazoo Zaka (Pvt) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/schazoo-zaka-pvt-ltdGenerated 11 Nov 2026M/s. Genix Pharma (Pvt) Ltd.18 shared67% overlapHilton Pharma (Pvt) Limited.17 shared63% overlapWerrick Pharmaceuticals17 shared63% overlapHIGH-Q Pharmaceuticals17 shared63% overlapGenome Pharmaceuticals (Pvt.) Ltd.17 shared63% overlapNabiqasim Industries (Pvt) Ltd.,16 shared59% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives41 products · 68%
Cardiovascular11 products · 18%
CNS & mental health3 products · 5%
Pain & musculoskeletal2 products · 3%
Hematology & thrombosis1 products · 2%
Vitamins, minerals & nutrition1 products · 2%
Gastrointestinal & hepatology1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antimycobacterials19 products · 32%
Antimalarials8 products · 13%
Calcium-channel blockers8 products · 13%
Macrolide antibacterials6 products · 10%
Fluoroquinolone antibacterials5 products · 8%
Antivirals3 products · 5%
Antipsychotics3 products · 5%
Angiotensin II receptor blockers2 products · 3%
Formulation footprint

Dosage forms

Tablet48 products
Capsule8 products
Suspension2 products
Drops1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 TelmipinTelmisartan + Amlodipine 6presentations 40 mg + 10 mg, 40 mg + 5 mg, 80 mg + 10 mg, 80 mg + 5 mg · Tablet #2 RespimaxClarithromycin 4presentations 125 mg, 125 mg/5 mL, 250 mg, 500 mg · Drops, Suspension, Tablet #3 RifapinRifampicin 4presentations 100 mg, 150 mg, 300 mg, 450 mg · Syrup, Capsule, Tablet #4 BizoleRibavirin 3presentations 100 mg, 200 mg, 400 mg · Capsule #5 RevesRisperidone 3presentations 1 mg, 2 mg, 3 mg · Tablet #6 RifapinRifampicin + Isoniazid 3presentations 150 mg + 100 mg, 300 mg + 150 mg, 450 mg + 300 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Schazoo Zaka (Pvt) Ltd is priced against the market

52 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

M/s. Genix Pharma (Pvt) Ltd.292 products · 98 generics 18shared generics Hilton Pharma (Pvt) Limited.262 products · 61 generics 17shared generics Werrick Pharmaceuticals245 products · 81 generics 17shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers56Distinct registrations among indexed, published, presentation-validated products only
Verified price observations60
Products with a verified price60
Products with multiple price observations0
Source records with multiple versions60
Latest portfolio source check22 Sep 2026
Latest effective price date22 Jul 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

61 unique registration(s) · 60 indexed presentation(s) · 2 additional source-observed presentation(s) · 3 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Athofix Azithromycin 200 mg/5 mL Dry suspension 15ml 030096 PKR 314.07 PKR 20.94/mL 🔒 Pharma Pro
Athofix Azithromycin 250 mg Capsule 1x6 030097 PKR 376.91 PKR 62.82/capsule 🔒 Pharma Pro
Bizole Ribavirin 100 mg Capsule 1x10 028899 PKR 318.47 PKR 31.85/capsule 🔒 Pharma Pro
Bizole Ribavirin 200 mg Capsule 1x10 028900 PKR 516.32 PKR 51.63/capsule 🔒 Pharma Pro
Bizole Ribavirin 400 mg Capsule 1x10 028901 PKR 826.12 PKR 82.61/capsule 🔒 Pharma Pro
Ciprol Ciprofloxacin 250 mg Tablet 1x10 016634 PKR 182.97 PKR 18.30/tablet 🔒 Pharma Pro
Ciprol Ciprofloxacin 500 mg Tablet 1x10 016635 PKR 351.30 PKR 35.13/tablet 🔒 Pharma Pro
Co-telisartan Telmisartan + Hydrochlorothiazide 40 mg + 12.5 mg Tablet 14`s 069282 PKR 670.29 PKR 47.88/tablet 🔒 Pharma Pro
Cubac Levofloxacin 250 mg Tablet 1x10's 047942 PKR 516.32 PKR 51.63/tablet 🔒 Pharma Pro
Cubac Levofloxacin 500 mg Tablet 1x10's 049943 PKR 859.14 PKR 85.91/tablet 🔒 Pharma Pro
Cyclosen Cycloserine 250 mg Capsule 30's 035272 PKR 5,201.21 PKR 173.37/capsule 🔒 Pharma Pro
Dogrel Clopidogrel 75 mg Tablet 2x6 029047 PKR 351.77 PKR 29.31/tablet 🔒 Pharma Pro
Eraquin Hydroxychloroquine 200 mg Tablet 50`s 106106 PKR 635.70 PKR 12.71/tablet 🔒 Pharma Pro
Eraquin Hydroxychloroquine 200 mg Tablet 30`s 106106 PKR 381.42 PKR 12.71/tablet 🔒 Pharma Pro
Ethomid Ethionamide 250 mg Tablet 3x10 024952 PKR 1,016.99 PKR 33.90/tablet 🔒 Pharma Pro
Ferozak Iron polymaltose complex + Folic acid 100 mg + 0.35 mg Tablet 4x5 054417 PKR 348.54 PKR 17.43/tablet 🔒 Pharma Pro
Lodipin Amlodipine 5 mg Tablet 2x10 020994 PKR 262.04 PKR 13.10/tablet 🔒 Pharma Pro
Lodipin Amlodipine 10 mg Tablet 2x10 020995 PKR 540.17 PKR 27.01/tablet 🔒 Pharma Pro
Lotense Losartan 50 mg Tablet 2x10 029534 PKR 486.51 PKR 24.33/tablet 🔒 Pharma Pro
Lotense Losartan 25 mg Tablet 2x10 038122 PKR 237.85 PKR 11.89/tablet 🔒 Pharma Pro
Malfan Artemether + Lumefantrine 20 mg + 120 mg Tablet 2x8 054415 PKR 660.90 PKR 41.31/tablet 🔒 Pharma Pro
Malfan Artemether + Lumefantrine 20 mg + 120 mg Dispersible tablet 2x8 064785 PKR 660.90 PKR 41.31/tablet 🔒 Pharma Pro
Malfan DS Artemether + Lumefantrine 40 mg + 240 mg Tablet 1x8 054416 PKR 574.61 PKR 71.83/tablet 🔒 Pharma Pro
Malfan Forte Artemether + Lumefantrine 80 mg + 480 mg Tablet 1x6 067882 PKR 718.27 PKR 119.71/tablet 🔒 Pharma Pro
Malfan Forte Artemether + Lumefantrine 80 mg + 480 mg Tablet 1x4 067882 PKR 478.85 PKR 119.71/tablet 🔒 Pharma Pro
Mitanase Nasal SprayRegistry verified Mometasone Furoate nasal spray — — — 136990Official source ↗ No indexed price — —
Moxizak Moxifloxacin 400 mg Tablet 1x5 054418 PKR 981.03 PKR 196.21/tablet 🔒 Pharma Pro
Neobutinal Ibuprofen 200 mg Tablet 10x10 018074 PKR 424.58 PKR 4.25/tablet 🔒 Pharma Pro
Neobutinal Ibuprofen 400 mg Tablet 10x10 019202 PKR 399.81 PKR 4.00/tablet 🔒 Pharma Pro
Pyrazid Pyrazinamide 500 mg Tablet 5x10 008901 PKR 506.98 PKR 10.14/tablet 🔒 Pharma Pro
Pyrazid Pyrazinamide 400 mg Tablet 1x50 071497 PKR 264.36 PKR 5.29/tablet No comparator
Qunizak Chloroquine 250 mg Tablet 50`s 106107 PKR 579.26 PKR 11.59/tablet 🔒 Pharma Pro
Respimax Clarithromycin 125 mg/5 mL Dry suspension 60ml 047939 PKR 460.57 PKR 7.68/mL 🔒 Pharma Pro
Respimax Clarithromycin 250 mg Tablet 1x10 047940 PKR 509.56 PKR 50.96/tablet 🔒 Pharma Pro
Respimax Clarithromycin 500 mg Tablet 1x10 047941 PKR 919.06 PKR 91.91/tablet 🔒 Pharma Pro
Respimax Clarithromycin 125 mg Oral drops 25ml 064788 PKR 154.91 PKR 6.20/mL No comparator
Reves Risperidone 1 mg Tablet 1x10 053615 PKR 275.26 PKR 27.53/tablet 🔒 Pharma Pro
Reves Risperidone 2 mg Tablet 1x10 053616 PKR 447.30 PKR 44.73/tablet 🔒 Pharma Pro
Reves Risperidone 3 mg Tablet 1x10 053617 PKR 688.12 PKR 68.81/tablet 🔒 Pharma Pro
Rifa Rifampicin + Isoniazid + Ethambutol 150 mg + 75 mg + 275 mg Tablet 1x30 077006 PKR 185.87 PKR 6.20/tablet 🔒 Pharma Pro
Rifa 2 Rifampicin + Isoniazid 150 mg + 75 mg Tablet 1`s 077005 PKR 6.68 PKR 6.68/tablet 🔒 Pharma Pro
Rifa 4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol 120 mg + 225 mg + 60 mg + 300 mg Tablet 10x10 016637 PKR 3,397.91 PKR 33.98/tablet No comparator
Rifa 4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol 150 mg + 275 mg + 75 mg + 400 mg Tablet 10x10 024232 PKR 4,081.20 PKR 40.81/tablet No comparator
Rifapin Rifampicin 150 mg Capsule 1x8 006945 PKR 45.44 PKR 5.68/capsule 🔒 Pharma Pro
Rifapin Rifampicin 450 mg Tablet 1x8 006946 PKR 134.83 PKR 16.85/tablet 🔒 Pharma Pro
Rifapin Rifampicin + Isoniazid 300 mg + 150 mg Tablet 10x10 008357 PKR 4,332.51 PKR 43.33/tablet 🔒 Pharma Pro
Rifapin Rifampicin 300 mg Capsule 1 009933 PKR 6.65 PKR 6.65/capsule 🔒 Pharma Pro
Rifapin Rifampicin 100 mg Syrup 60ml 013082 PKR 45.28 PKR 0.75/mL No comparator
Rifapin Rifampicin + Isoniazid 450 mg + 300 mg Tablet 10x10 013083 PKR 6,406.70 PKR 64.07/tablet 🔒 Pharma Pro
Rifapin Rifampicin + Isoniazid 150 mg + 100 mg Tablet 10x10 013594 PKR 883.90 PKR 8.84/tablet No comparator
A to Z

All 31 Schazoo Zaka brands in Pakistan

  • Athofix Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
  • Bizole Ribavirin · 100 mg capsule, 200 mg capsule, 400 mg capsule
  • Ciprol Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • Co-telisartan Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet
  • Cubac Levofloxacin · 250 mg tablet, 500 mg tablet
  • Cyclosen Cycloserine · 250 mg capsule
  • Dogrel Clopidogrel · 75 mg tablet
  • Eraquin Hydroxychloroquine · 200 mg tablet
  • Ethomid Ethionamide · 250 mg tablet
  • Ferozak Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
  • Lodipin Amlodipine · 10 mg tablet, 5 mg tablet
  • Lotense Losartan · 25 mg tablet, 50 mg tablet
  • Malfan Artemether + Lumefantrine · 20 mg + 120 mg tablet
  • Malfan DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
  • Malfan Forte Artemether + Lumefantrine · 80 mg + 480 mg tablet
  • Moxizak Moxifloxacin · 400 mg tablet
  • Neobutinal Ibuprofen · 200 mg tablet, 400 mg tablet
  • Pyrazid Pyrazinamide · 400 mg tablet, 500 mg tablet
  • Qunizak Chloroquine · 250 mg tablet
  • Respimax Clarithromycin · 125 mg drops, 125 mg/5 mL suspension, 250 mg tablet
  • Reves Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Rifa Rifampicin + Isoniazid + Ethambutol · 150 mg + 75 mg + 275 mg tablet
  • Rifa 2 Rifampicin + Isoniazid · 150 mg + 75 mg tablet
  • Rifa 4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol · 120 mg + 225 mg + 60 mg + 300 mg tablet, 150 mg + 275 mg + 75 mg + 400 mg tablet
  • Rifapin Rifampicin, Rifampicin + Isoniazid · 100 mg syrup, 150 mg capsule, 150 mg + 100 mg tablet
  • Rifatol Rifampicin + Isoniazid + Ethambutol · 150 mg + 300 mg + 75 mg tablet
  • Rifazak Pyrazinamide Rifampicin + Isoniazid + Pyrazinamide · 150 mg + 60 mg + 30 mg tablet
  • Rifazol Plus Rifampicin + Isoniazid + Pyrazinamide · 150 mg + 75 mg + 400 mg tablet
  • Schazobutol Tabs Ethambutol · 400 mg tablet
  • Telmipin Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
  • Zoprol Omeprazole · 20 mg capsule
Questions

Schazoo Zaka: common questions

How many products does Schazoo Zaka have in Pakistan?

Schazoo Zaka (Pvt) Ltd has 60 registered medicine presentations in Pakistan, sold under 31 brands and covering 27 generic medicines.

What are the main brands of Schazoo Zaka?

By number of registered strengths and packs, its largest brands are Rifapin (Rifampicin, Rifampicin + Isoniazid), Telmipin (Telmisartan + Amlodipine), Respimax (Clarithromycin), Bizole (Ribavirin) and Reves (Risperidone). This is not a sales ranking.

Which therapy areas does Schazoo Zaka cover?

The most products are in Anti-infectives (41), Cardiovascular (11), CNS & mental health (3), Pain & musculoskeletal (2) and Hematology & thrombosis (1).

Where can I see Schazoo Zaka medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Schazoo Zaka (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/schazoo-zaka-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9